Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-04

Clinical Trial Update: Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing nalbuphine to ketamine for prevention of emergence agitation after sevoflurane in children undergoing tonsillectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Ain Shams University | Conditions: Pediatric ALL, Pediatric Anesthesia | Phase 4 | Status: COMPLETED